Calumet, Inc. /DE (CLMT) FY2026 YTD Q2 P&L / Income Statement
2026-01-01 to 2026-06-30
Revenue by Business Segment
2026-01-01 to 2026-06-30
Swipe to see the full flow
Chart details
Calumet, Inc. /DE (CLMT) FY2026 YTD Q2 P&L / Income Statement
Income statement for 2026-01-01 through 2026-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Sales
- 2,474,900,000 US dollars
- Cost of sales
- 2,544,000,000 US dollars
- Gross profit (loss)
- negative 69,100,000 US dollars
- Operating costs, including other operating expenses (calculated)
- 142,200,000 US dollars
- Operating loss
- negative 211,300,000 US dollars
- Total other income (expense)
- negative 243,700,000 US dollars
- Net loss before income taxes
- negative 455,000,000 US dollars
- Income tax (benefit) expense
- negative 42,100,000 US dollars
- Net loss
- negative 412,900,000 US dollars
- Specialty Products and Solutions
- 1,730,400,000 US dollars
- Performance Brands
- 192,600,000 US dollars
- Montana/ Renewables
- 564,900,000 US dollars
- General and administrative
- 105,400,000 US dollars
- Selling
- 25,800,000 US dollars
- Other operating expense
- 11,000,000 US dollars
- Gain on sale of business
- 0 US dollars
- Revenue before reconciliation (calculated)
- 2,487,900,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- Inter-segment sales eliminations
- negative 13,000,000 US dollars. Reported reconciliation to consolidated revenue.
Chart connections
- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Gross margin
−2.8%
Gross profit / revenue
Operating margin
−8.5%
Operating profit / revenue
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
